(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

US NEUROPATHY CENTERS

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

US NEUROPATHY CENTERS

ST13

US500000085764309

Class

44

Filing

85764309

Registration

4366240

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

29

Latest update

01/27/2023

Trademark type

Word

Nice classes

44

Filing date

10/26/2012

Registration date

07/09/2013

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

01/27/2023

Last transaction

01/27/2023

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Supplemental Register

Filing basis

Intent to use

First use anywhere

01/08/2013

First use in commerce

01/08/2013

Drawing code

4

Owner type

01

Owner location

Marietta, AZ, US

Examiner

MCDORMAN, ROGER THOMAS

Law office

L90

Current location

GENERIC WEB UPDATE

Holders and representatives

Holders

Barrett, Stephen L.
Barrett, Stephen L.

Representatives

Barrett, Stephen L.

Technical classification

Nice Classes

Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 44

Providing multimodal treatment for peripheral neuropathy

Publications

History of USPTO decisions and trademark events.

29 publications found

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

01/27/2023

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

01/27/2023

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

01/27/2023

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

01/27/2023

E89R

TEAS SECTION 8 & 9 RECEIVED

07/12/2022

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

07/09/2022

NAS8

NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED

10/09/2018

8.OK

REGISTERED - SEC. 8 (6-YR) ACCEPTED

10/09/2018

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

10/05/2018

ES8R

TEAS SECTION 8 RECEIVED

10/03/2018

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

10/03/2018

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

07/09/2018

R.SR

REGISTERED-SUPPLEMENTAL REGISTER

07/09/2013

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

06/05/2013

ALIE

ASSIGNED TO LIE

06/04/2013

AAUA

NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED

05/18/2013

CNTA

APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER

05/17/2013

IUAA

USE AMENDMENT ACCEPTED

05/17/2013

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

05/11/2013

AUPC

AMENDMENT TO USE PROCESSING COMPLETE

05/10/2013

IUAF

USE AMENDMENT FILED

05/10/2013

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

05/09/2013

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

05/09/2013

EAAU

TEAS AMENDMENT OF USE RECEIVED

05/09/2013

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

04/16/2013

GNRT

NON-FINAL ACTION E-MAILED

04/16/2013

CNRT

NON-FINAL ACTION WRITTEN

04/16/2013

DOCK

ASSIGNED TO EXAMINER

02/25/2013

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

11/01/2012

Continuous trademark protection

Get notified about every new filing that threatens US NEUROPATHY CENTERS or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.